Evaluation of the Effects of a Monthly Buprenorphine Depot Subcutaneous Injection on QT Interval During Treatment for Opioid Use Disorder

Extensive 12‐lead electrocardiogram monitoring and drug concentrations were obtained during development of BUP‐XR, a monthly subcutaneous injection for the treatment of opioid use disorder (OUD). Matched QT and plasma drug concentrations (11,925) from 1,114 subjects were pooled from 5 studies in OUD...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmith, Virginia D., Curd, Laura, Lohmer, Lauren R. L., Laffont, Celine M., Andorn, Anne, Young, Malcolm A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766787/
https://www.ncbi.nlm.nih.gov/pubmed/30801681
http://dx.doi.org/10.1002/cpt.1406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766787/
https://www.ncbi.nlm.nih.gov/pubmed/30801681
http://dx.doi.org/10.1002/cpt.1406

Ejemplares similares